References
- Welch G. N., Loscalzo J. Homocysteine and atherothrombosis. New England Journal of Medicine 1998; 338: 1042–1050
- Roubenoif R., Dellaripa P., Nadeau M. R., Abad L. W., Muldoon B. A., Selhub J., Rosenberg I. H. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheumatology 1997; 40: 718–722
- Gao X. M., Wordsworth P., McMichael A. J., Kyaw M. M., Seifert M., Rees D., Dougan G. Homocysteine modification of HLA antigens and its immunological consequences. European Journal of Immunology 1996; 26: 1443–1450
- Parker J. E., Mufti G. J. Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes. British Journal of Haematology 1998; 101: 220–230
- Peddie C. M., Wolf C. R., McLellan L. I., Collins A. R., Bowen D. T. Oxydative DNA damage in CD34 + myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumor necrosis factor-α concentration. British Journal of Haematology 1997; 99: 625–631
- Cighetti G., Debiasi S., Paroni R., Allevi P. Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. Analytical Biochemistry 1999; 266: 222–229
- Bamonti-Catena F., Porcella A., Pomati M., Franzini C., Rosina M., Cavalca V., Maiolo A. T. Whole blood folate concentrations: comparison between Stratus Folate (Dade) and radioassay (DPC) methods. European Journal Clinical Chemistry and Clinical Biochemistry 1997; 35: 781–785
- Cortelezzi A., Cappellini M. D., Sarina B., Cristiani S., Duca L., Silvestris I., Lambertenghi Delilliers G., Fiorelli G. High levels of serum non transferrin-bound irons in myelodysplastic syndromes. Leukemia Research 1999; 23(Suppl 1)S22
- Wickramasinghe S. N. The wide spectrum and unresolved issues of megaloblastic anemia. Seminars in Hematology 1999; 36: 3–18
- Green R., Miller J. W. Folate deficiency beyond megaloblastic anemia: hyperhomocysteinemia and other manifestation of dysfunctional folate status. Seminars in Hematology 1999; 36: 47–64
- Wollman M. R., Penchansky L., Shekhter-Levin S. Transient 7q-in association with megaloblastic anemia due to dietary folate and vitamin B12 deficiency. Journal of Pediatric Hematology Oncology 1996; 18: 162–165
- Cortelezzi A., Cattaneo C., Sarina B., Cristiani S., Pomati M., Silvestris I., Motta M., Ibatici A., Gornati G., Delia Volpe A., Maiolo A. T. Efficacy of N-acetylcysteine and all-trans retinoic acid in restoring in vitro effective hemopoiesis in myelodysplastic syndromes. Leukemia Research 2000; 24: 129–137
- Tsunematsu Y., Koide R., Sasaki M., Takahashi H. Acute myeloid leukemia with preceding systemic lupus erythematous and autoimmune hemolytic anemia. Japanese Journal of Clinical Oncology 1984; 14: 107–113
- Ahmad Y. H., Kiehl R., Papac R. J. Myelodysplasia. The clinical spectrum of 51 patients. Cancer 1995; 76: 869–874
- Jaeger U., Panzer S., Bartram C., Haas O., Volc-Platzer B., Graninger W., Geissler K., Radaszkiewicz T., Lechner K. Autoimmune-thrombocytopenia and SLE in a patient with 5q-anomaly and deletion of the c-fms oncogene. American Journal of Hematology 1994; 45: 79–80
- Hull D. R., McMillan S. A., Rea I. M., Boyd N., McMullin M. F. Antineutrophil cytoplasmic antibodies in myelodysplasia. Ulster Medicine Journal 1996; 65: 55–57